chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 hours after administration: rash/hives on left elbow and upper left quandrant on back with chills. PCP contacted. The next day 9/14 she said that the rash and chills had resolved.
Also discussed administering her initial Pfizer COVID19 vaccine. Inadvertently ordered a Pfizer 6month to 4 year bivalent SARS-COV-2 vaccine and this was administered as the first dose in her primary series.
25.4mm x 13.5mm, oral steroids Benadryl PO Keflex.
Coughing increased to point of infection along with malaise and fever and antibiotics were prescribed. Patient was ill for 2-3 weeks.
Left arm red and swollen from shoulder to elbow. Warm and sensitive to touch. Lump at site of injection. White pimples on rest of arm area. Nurse discussed reaction with parent and referred to PCP. Child is being seen 12/4/03 by PCP.
Patient started feeling left arm joint pain including intermittent ache with and without movement.  Pain alleviated with no intervention and came back a few days later.  Patient had no other symptoms.
Redness in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness in the left arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history).    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness in the left arm). At the time of the report, VACCINATION SITE ERYTHEMA (Redness in the left arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
p/vax rt thish @ inject sit was swollen (knot like), cried all day, t101-102 R-used cold compress & APAP, woke up aobut every hr @ noc; 8DEC92 still cranky, t101 R;
mom states pat w/temp starting p/vax to 104 dec APAP to 1--;not ususal self;given APAP & pedialyte;seen 22MAR w/MD mom states told could be from vaccine.  Mother states child with temperature starting after vaccines to 104 degrees decrease with Tylenol to 100. "not her usual self" given Tyleonol and Pedialyte. Seen 3/22 with doctor. Mother states told could be from vaccine. Doctor's nurse states doctor said child ok and mother advised of this again today.
ILL; This case was reported by a pharmacist via call center representative and described the occurrence of unwell in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced unwell. On an unknown date, the outcome of the unwell was recovered/resolved.   It was unknown if the reporter considered the unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient got ill after receiving 1st dose of Shingrix. The reporter stated that, the healthcare professional was not at work and could not provide patient demographics, lot number, or expiration dates. The health care provider had not provided any other information. The reporter noted that the patient was a physician and would be contacting GlaxoSmithKline with additional details. This case has been linked with case US2019092174, reported by the same reporter.
FLU LIKE SYMPTOMS; INTENSE FATIGUE; MILD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced flu like symptoms, intense fatigue, and mild headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the intense fatigue, flu like symptoms and mild headache was not reported. This report was non-serious. This case, from the same reporter is linked to 20210412169.
Started off as sharp back pain on left side coming and going for several weeks, beginning on April 12, 2021. On May 4, 2021 she went to the emergency room and was diagnosed with kidney stones.
mild tightening in my throat; slight discomfort in swallowing; This is a spontaneous report from a contactable consumer (patient). A 61-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Left arm on 10Mar2021 14:15 (at the age of 61-year-old) as dose number unknown, single for covid-19 immunisation. Medical history included high cholesterol, hay fever (seasonal) allergies. No other known allergies reported. Concomitant medication included Atorvastatin 10 mg daily. Patient did not receive any other vaccine in four weeks. Patient did not have covid prior vaccination and had not covid tested post vaccination. On 10Mar2021 15:30, about an hour after the injection, patient felt a mild tightening in throat and slight discomfort in swallowing. Enough to notice but not cause any real difficulty in swallowing. It lasted for about an hour and a half. Patient did not receive any treatment for adverse events. The outcome of the events was recovered on 10Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
arm pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th December 2019, the patient received the 1st dose of Shingrix. On 26th December 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received his 1st dose of Shingrix and experienced arm pain. The reporter consented to follow up.
Pt complaint: "heart racing, hot flash, feeling like fainting if I stand up" approx. 10 mins post 16:30 vaccine admin. RN & another RN checked pt's vitals & BS. 16:45- BP 130/105, HR 160, O2 100%. 16:48- BP 148/93, HR 96, O2 98%. 17:00- BP 123/86, HR 68, O2 100%. 17:20- BP 122/86, HR 97, O2 92%. BS 83 @17:15. Pt received H2O, ice pack & elevated feet on chair. Pt noted symptom resolution & MD evaluated & walked pt back to work site.
Phlebitis RIGHT ARM SUDDENLY WITH REDNESS, WARMTH PAIN ON 1/6 AFTER VACCINE ON 12/29 Narrative:
Got shot at noon 10/05/04; Very tired early evening; woke up at 2:40 AM very HOT and damp. My bedroom is not heated, so is about 50degrees; all i could tolerate was a sheet up to my waist. I was that hot all night. I had nightmares; very vivid; caused anxiety; very shaky and weak this morning with lack of concentration; fingers don't seem to want to work.
The next day, 1/13 I woke up I could not even move my left arm for three days I had to leave the same shirt on my legs were very very itchy but if I would scratch them and stung very bad but yet there was no rash and my hips eight and since I had that shot I?m still achy all over and I never had this problem before I?m a very healthy person I can continue to have constant lower back pain
Rash on left side of trunk.    Shingles outbreak - no blisters  lethargic, chest tightness
10/4/17 0300 hrs. left arm, left neck and left chest were stiff. 10/4/17 1000 hrs. chills, cold, face flushed. No fever. 10/5/17 woke up feeling better. Minimal stiffness in left arm, and minimal aches.
loss of functionality of left arm, triceps issues, numbness in fingers, paralysis of left arm
Information has been received from a healthcare worker concerning a male who on 26-SEP-2008 was vaccinated with PNEUMOVAX (lot #658074/0961U) 0.5 mL/one dose IM. On 26-SEP-2008 after receiving the dose of PNEUMOVAX, the patient experienced swelling, pain, cellulitis and fever in the arm of PNEUMOVAX. The healthcare worker reported that the patient was seen in the practice. At the time of reporting the patient had not recovered from swelling, pain cellulitis and fever. No further information was provided. This is one of two reports received from the same source. Additional information has been requested.
Initially some itching and swelling on the 15th wasn't really concerned. Today Tuesday 03/17/15 woke up with a raised red rash about an inch wide and 2 to 3 inches long coming down from injection site on left arm.
Information has been received from a certified medical assistant (C.M.A.), for GARDASIL, a Pregnancy Registry product, concerning an approximately 24 years old female patient with no drug reactions/allergies and a history of irregular menstrual cycle who on 20-JUL-2010 was vaccinated intramuscularly with her first 0.5mL dose of GARDASIL (lot number 666121/1778Y). Concomitant therapy included prenatal vitamins (therapy unspecified). The medical assistant reported that on 29-AUG-2010, the patient was seen in the emergency room for shortness of breath, while there she was tested for a pregnancy test and was positive. No report from the emergency room on the shortness of breath had been received. At the time of report, the patient's shortness break outcome was unknown. Last menstrual period (LMP), 10-JUN-2010. Her estimated date of delivery (EDD) was 17-MAR-2011. Follow-up information has been received from a registered Nurse via a telephone call, who reported that the patient delivered vaginally a healthy male neonate on 27-MAR-2011. The neonate weight at birth was reported as 6 pounds, 1 ounce. Gestational age was 39 weeks. APGAR scores were 8/9. There were no congenital anomalies noted in the OB/delivery report. Additional information is not expected.
she has some concerns regarding one specific lot number that 15% of their breakthrough cases had received. The lot number provided; she has some concerns regarding one specific lot number that 15% of their breakthrough cases had received. The lot number provided; Tested positive for Covid virus, after being fully vaccinated; Tested positive for Covid virus, after being fully vaccinated; This is a spontaneous report from a contactable consumer. A 38-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: EN6203) via an unspecified route of administration on 23Feb2021 as DOSE 2, SINGLE, and first dose via an unspecified route of administration on 27Jan2021 (Batch/Lot Number: EN5318) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 01Aug2021, the patient tested positive for covid virus, after being fully vaccinated. It was reported that, patient has some concerns regarding one specific lot number that 15% of their breakthrough cases had received. Reporter reclarified later in report that 15% of the breakthrough cases in her county had the same lot number, which was concerning. Reporter stated, she has 37 patients with partial identifiers. She cannot provide some identifying details and that she would need to check with her legal department first. Reporter provided the details she was allowed to identify. Reporter stated she can provide, age, gender, BMI, medical conditions, if reported, and date they tested positive for Covid, and the type of covid test utilized, she cannot provide the zip code. The patient underwent lab tests and procedures which included body mass index: 20 on 01Aug2021  and sars-cov-2 test: positive on 01Aug2021. The outcome of the event was unknown.   Follow-up attempts are completed. No further information is expected.
3" x 3.5" very red spot 1" below shot appeared on the day after the shot.  I ran low grade fever for a day.  The spot was warm to touch and my arm hurt to move.  The arm was swollen.  I had the shot on Tuesday. Saturday, the redness is less, the spot is still warm, and hurts to touch.
Patient was put to bed normally on 12/04/06.  Parents woke 12/5 a.m. to find baby unresponsive, pronounced dead at the scene.  Medical examiner preliminary report- suspected SIDS.  3/15/07 Received Autopsy Report which reveals COD as Sudden Unexplained Infant Death Syndrome.
Pt says she has a knot at the injection site that developed day after the injection and hasn't gone away even though it's been a week. According to the patient, she has a family history of blood clots and pulmonary embolisms. She was  advised to contact her primary care provider and get the proper diagnostic tests.
Towards the end of 30 minute waiting period following the vaccine, I noticed red hives(red swollen bumps) that were slightly itchy on my left wrist. Later in the evening,  my lips and tongue felt odd and a bit numb.  Lips and roof of mouth continued to feel strange the next day and my throat was a little scratchy.  When I awoke in morning, there was also a patch of hives (identical to those that were on my wrist) on my chest - about a 3" diameter.  All symptoms dissipated about 24 hours after initial onset.
This spontaneous report as received from a nurse refers to a male patient of unknown age. The patient's wife was vaccinated with a dose of ZOSTAVAX on approximately two weeks ago at an unspecified pharmacy but he was not vaccinated with ZOSTAVAX. On 27-JUL-2012 (reported as three days ago) the patient experienced shingles lesions on the left side of his head and also his left eye. The patient was prescribed acyclovir and  VIROPTIC for the adverse events. The outcome of the patient was unknown. The nurse was not aware of the patient's wife developing any kind of lesions or symptoms after receiving ZOSTAVAX. The nurse did not know who her physician was or if she had needed to seek medical attention. Additional information has been requested.
Information has been received from a pharmacist for GARDASIL a Pregnancy Registry Product, concerning a 20 year old female with allergies (unspecified) and no drug reactions/allergies. On 13-JAN-2012 was vaccinated, with first dose of GARDASIL (lot # unspecified), 0.5 ml, injection, intramuscularly (IM). On 23-MAR-2012 the patient was vaccinated with the second dose of GARDASIL (lot # unspecified), 0.5 ml, IM. Concomitant therapy included omeprazole (manufacturer unknown) and CLARITIN taken as needed. On an unspecified date, the patient became pregnant. The patient mentioned after receiving the 2nd dose of GARDASIL that she did not have a period since December 2011. The patient was given a urine pregnancy test in the office visit on 23-MAR-2012 which was positive for pregnancy. No treatment was given. The patient's Last Menstrual Period (LMP) was in December 2011 and her estimated delivery date (EDD) was 06-SEP-2012. At the time of report, the outcome was unknown. Follow up information has been received on 14-DEC-2013 from a pharmacist. It was reported that the patient terminated pregnancy electively at 20 weeks (in 2012). Fetal outcome was unknown. It was also reported that anatomy ultrasound prior to termination (date unknown) did not indicated any abnormalities. Relatedness between elective termination and GARDASIL was not assessed. Upon internal review elective termination was considered to be medically significant. Additional information is not expected.
Pt's skin was black and blue at the injection site and was red and swollen at the pneumonia site.
Pt came back the day after vaccine administration and showed me a red, hot, swollen bruised place on her arm where the vaccine was administered
L deltoid with 5cm X 8cm area of swelling/redness/mild warmth and induration developed about 40 hrs after Boostrix vaccine. Started to improve when pt examined here about 72 hrs after vaccine with decreased redness/swelling. Giving Benadryl and ibuprofen.
Pfizer vaccine administered after being stored at regular freezer temps longer than recommended.  Dose determined invalid, client contacted and recommended dose repeated.
Narrative: COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 02/22, Pfizer, dose #2 10/22, Pfizer, dose #3 08/26 pt cc: cough, fatigue, headache, myalgias, nausea, dyspnea, sore throat, vomiting exposure; unknown 10/29 COVID swab, result: detected 10/30 pt admit to Medicine cc: chest pain dx: COVID-19+ LOS: 5 days 11/01 FIBRINOGEN: 336 11/01 DDIMER: 0.22 11/01 ESR: 29 11/02 SARS-COV-S TOTAL AB, SPIKE: >2500.0 11/02 ESR: 41 11/02 DDIMER: 0.29 11/02 SARS-COV2-IgG: 4.75 11/03 ESR: 19
Red and warm spot on the arm that itches. The initial inject was painless and then by the next day my arm was very sore to the touch. Gradually that pain subsided. Upon waking up this morning I noticed the injection site had redness, felt warm and was itching quite a lot.
Mother and infant in for 2nd series. Mom states that infant cried inconsolably X 5 hours, post vax. Did not take to MD. Mom thought it might be colic.
I got the Moderna booster at the pharmacy yesterday afternoon, Monday, 12/06/2021. Was sick yesterday evening and today (aches, lymph pain, swelling at the injection site), and today I had to leave work early after only an hour and a half due to wooziness. When I got home, I fell asleep right away. On waking, I tried to eat, and immediately passed out in the kitchen. I am still trying to figure out whether to go to the ER or not.
Patient should have received MMR Vaccine, but was given Proquad Vaccine instead. Patient was notified, and no reactions were observed.
This spontaneous report as received from a Doctor of pharmacy refers to an unspecified number of patients. On an unknown date, the patients were vaccinated with a dose of ZOSTAVAX (Lot # not reported). The pharmacist reported that on unknown dates, the patients might have experienced bleeding after administration of ZOSTAVAX. At the time of the report, the patients' outcome was unknown. Additional information has been requested.
Admitted to hospital on 8/10/2021 with confirmed Covid, symptoms of generalized weakness, increased SOB, exhaustion and fever.   Dose # 1 given 2/24/21 Dose#2 given 3/17/2021
This case was reported by a other health professional via call center representative and described the occurrence of nausea in an unspecified number of the adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced nausea. On an unknown date, the outcome of the nausea was unknown. It was unknown if the reporter considered the nausea to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per the vaccine indication. The healthcare professional reported that the patients experienced nausea post 1st dose of SHINGRIX. No further information was available.
Tiredness & slight achy ness. These side effects did not keep me from doing the normal things I would do in the course of my afternoon. They continued for 4 days after the shot.
Left upper arm became red and swollen. Arm became painful as the evening went on, patient took OTC TYLENOL. Pt had trouble sleeping due to pain/discomfort, took a TYLENOL #3. Took OTC TYLENOL on Sunday. Swelling was reducing.
Patient called to say after she got out of the shower this morning, she noticed a "pickle jar lid-sized red spot" beneath the site of injection. She said it is tender and warm to touch. Pharmacist recommended to use cold compress and Tylenol for pain (she was already on an NSAID) and referred to PCP if worsened or continued.
Lymph nodes under the left arm were swollen and tender, painful to touch; Lymph nodes under the left arm were swollen and tender, painful to touch.; chills; Painful injection site; Fever of 102.2 F; This is spontaneous report from contactable healthcare professional, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration in the left arm on 19Mar2021 at 09:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included macroprolactinemia. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route of administration in the left arm on 25Feb2021 at 16:30, (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 20:30 (during the day of vaccination), the patient experienced painful injection site and chills. In the evening, the patient had fever of 102.2 Fahrenheit (F), at this point the patient took unspecified medication and fever dropped to 101.3 F. On 20Mar2021, the entire day temperature hovered around 101 to 102 F and the patient slept the whole day. On 21Mar2021, the lymph nodes under the left arm were swollen, tender and painful to touch. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of painful injection site, fever of 102.2 F, chills and lymph nodes under the left arm were swollen and tender, painful to touch were recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
12/06/2021 I was very fatigued, had been in bed for 3 days. I had trouble getting a deep breath, very shallow breathing.  I saw my PCP and said I was okay. I was called back and told my oxygen level was low, dropping into the 80's. I was admitted to the hospital on 01/10/2022 - 01/14/2022. In the ER, I had x-rays, and said he had pneumonia. I was told I had COVID without having a test. I had bloodwork and a CT on my chest. The bloodwork was normal and said he did not have flu or pneumonia. The CT had not changed. I was discharged with antibiotic, oxygen, and prednisone. I went to see his PCP when I got home who told me to stop the prednisone and prescribed 3 Quetiapine Fumarate because I had not slept. I slept 12 hours and felt much better afterwards.
Pt recv vax on 3/3/99; on same day pt exp abdomen cramps, nausea, vomiting, diarrhea } x 3 days, vax site swelling/ red/ knot/ itch/ pain
Information has been received from a registered nurse concerning a female who "between the beginning of the September and now" (date not specified) was vaccinated IM with 0.5 ml dose of Gardasil vaccine (yeast). Subsequently on an unspecified date, the patient experienced a "definite stinging" at the injection site. Unspecified medical attention was sought. At the time of this report, the patients outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Had a on my second dose Fever, muscle pains and diognose with Rheumatoid Altritis after multiple xrays and blood tests. Taking folic acid, methotrexate and predniSONE.